No Detail Found!

Exendin-4: Orchestrating Molecular Signals with Cellular Responses in Vascular Homeostasis

Author(s)
Ihab Harbieh Department of Basic Medical Sciences, College of Medicine, Sulaiman AlRajhi University, AlBukayriyah, 51941, Qassim, Saudi Arabia
Eslam Kamal Fahmy College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Mohammed M. Ismail College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Padmanabha College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
A. Alenezi Mohammad Matar College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Safya Ebraheem Esmaeel College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
S. Anil Mohan Rao College of Medicine, Northern Border University (NBU), 91431, Arar, Saudi Arabia
Baraah Abu Alsel Medical Sciences and Preparatory Year Department, North Private College of Nursing, 73312, Arar, Saudi Arabia
Ahmed Kamal Elbana Faculty of Medicine, Al Azhar University, Cairo, Egypt
Abstract
Exendin-4, a potent glucagon-like peptide-1 receptor (GLP-1R) agonist, has emerged as a critical modulator of vascular homeostasis beyond its established role in glucose metabolism. This review explores the multifaceted effects of Exendin-4 on vascular endothelial cells (ECs), vascular smooth muscle cells (VSMCs) and the surrounding immune microenvironment. We examine the ultrastructural and signaling pathways-including AMPK/SIRT1, PKA/Epac1 and Akt/eNOS- through which Exendin-4 preserves barrier integrity, inhibits pathological VSMC remodeling and attenuates atherosclerotic progression. By integrating evidence from recent clinical trials and basic cell biology, we highlight the therapeutic potential of Exendin-4 in treating vascular-related complications such as atherosclerosis, hypertension and ischemic injury (Figure 1).
Publication Details
Page(s) 63-68
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 5, Year: 2026

Request the full text from PASTIC

Keywords
Ischemic Injury, Atherosclerosis, Hypertension, GLP-1R, Exendin-4, Vascular Homeostasis
References
Levelt E. . .Diabetic Cardiomyopathy: Pathophysiology and Potential Metabolic Interventions State of the Art Review. European Journal of Endocrinology, 178(2018) : R127-R139.
Nagayama K.,Signaling JNK .2015 .Pathways. PLOS ONE, 0137960(9) : .
Ma X.,Potential Therapeutic . .GLP-1 Receptor Agonists (GLP-1RAs): Cardiovascular Actions. International Journal of Biological Sciences, 17(2021) : 2050-2068.
Xie Z.,AMPK-Dependent NF .2021 .Exendin-4 Preserves Blood-Brain Barrier Integrity via GLP-1R/. Inhibition after Subarachnoid Hemorrhage.” Frontiers in Molecular Neuroscience, 750726 : .
Jensen E.P. .2014 .Activation of GLP-1 Receptors on Vascular Smooth Muscle Cells Reduces the Autoregulatory Response in Afferent Arterioles and Increases Renal Blood Flow. American Journal of Physiology-Renal Physiology, 308(2015) : F867-F877.
Liu Z. .2018 .Exendin-4 Promotes the Vascular Smooth Muscle Cell Re-Differentiation through AMPK/SIRT1/FOXO3a Signaling Pathways. ” Atherosclerosis, 07 : 58-66.
Arakawa M. . .Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-Like Peptide-1 Receptor Agonist. , 59(2010) : 1694-1037.
Li A.Q.,Epac1-Dependent Rac1 A.Q. .2014 .Exendin-4 Promotes Endothelial Barrier Enhancement via PKA-. American Journal of Physiology-Cell Physiology, 308(2015) : C164-C175.
Lee J.,Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation .2022 .Migration in Vascular Smooth Muscle Cells and Ameliorates PhosphateInduced Vascular Smooth Muscle Cells Calcification. Diabetes & Metabolism Journal, 0363(2024) : 83-96.
Wang Y. . .Exendin-4 Decreases Liver Inflammation and Atherosclerosis Development Simultaneously by Reducing Macrophage Infiltration. British Journal of Pharmacology, 171(2014) : 723-734.
Yan C. .2023 .Exendin-4 Attenuates Atherosclerosis Progression via Controlling Hematopoietic Stem/Progenitor Cell Proliferation. ” Journal of Molecular Cell Biology, 15(3) : .
Du J. .2015 .Exendin-4 Induces Myocardial Protection through MKK3 and Akt-1 in Infarcted Hearts. American Journal of Physiology-Cell Physiology, 310(2016) : C270-C283.
Zhou H. .2015 .Exendin-4 Enhances the Migration of Adipose-Derived Stem Cells to Neonatal Rat Ventricular Cardiomyocyte-Derived Conditioned Medium via the Phosphoinositide 3-Kinase/Akt-Stromal Cell-Derived Factor1α/CXC Chemokine Receptor 4 Pathway. Molecular Medicine Reports, 3243(2015) : 4063-4072.
Ma X.,Potential Therapeutic . .GLP-1 Receptor Agonists (GLP-1RAs): Cardiovascular Actions. International Journal of Biological Sciences, 17(2021) : 2050-2068.
Sun Z. . .PEGylated Exendin-4, a Modified GLP-1 Analog Exhibits More Potent Cardioprotection than Its Unmodified Parent Molecule on a Dose to Dose Basis in a Murine Model of Myocardial Infarction. ” Theranostics, 5(2015) : 240-250.
Yu W.,Attenuate Glucose Toxicity-Induced Cardiac Liraglutide .2018 .Exendin-4. Oxidative Medicine and Cellular Longevity, : .
Zhou H. .2015 .Exendin-4 Enhances the Migration of Adipose-Derived Stem Cells to Neonatal Rat Ventricular Cardiomyocyte-Derived Conditioned Medium via the PI3K/Akt-SDF-1α/CXCR4 Pathway. Molecular Medicine Reports, 3243(2015) : 4063-4072.
Marso S.P. . .. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.” New England Journal of Medicine, 375(2016) : 311-322.
Punjabi M. .2022 .Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels.” JACC: Basic to Translational Science. , 08(2023) : 256-269.
McLean B.A. . .Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.” Endocrine Reviews. , 42(2020) : 101-132.
0

Citations

0

Downloads

15

Views